4.5 Article

Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Is there a relation between long non-coding RNA MALAT-1 and miRNA-9 in Egyptian patients with Vitiligo?

Nesreen M. Abo Raia et al.

Summary: This clinical biochemical study investigated the expressions of MALAT-1 and miR-9 in vitiligo patients, suggesting that these RNAs could serve as new diagnostic biomarkers due to their elevated levels in both serum and tissue of vitiligo patients. The findings indicate that miR-9 and MALAT-1 may have potential as biomarkers for vitiligo susceptibility, leading to new directions in its treatment.

EXPERIMENTAL DERMATOLOGY (2022)

Article Genetics & Heredity

LncRNA-mRNA co-expression network revealing the regulatory roles of lncRNAs in melanogenesis in vitiligo

Kunchi Pang et al.

Summary: In vitiligo, there are significant alterations in the expression of upregulated and downregulated lncRNAs, which play a role in regulating melanocyte function and melanogenesis. A total of 14 aberrantly expressed lncRNAs have been identified to regulate genes related to melanogenesis, suggesting their involvement in pathological mechanisms in melanocytes in vitiligo.

JOURNAL OF HUMAN GENETICS (2022)

Article Dermatology

Association between long noncoding RNA taurine-upregulated gene 1 and microRNA-377 in vitiligo

Maha Alhelf et al.

Summary: This study detected the expression levels of lncRNA TUG1, miRNA-377, PPAR-gamma, and IL-17 in vitiligo patients, finding that lncRNA TUG1 and PPAR-gamma were significantly downregulated, while miRNA-377 and IL-17 were significantly upregulated in the vitiligo group.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2022)

Article Immunology

Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients

Prashant S. Giri et al.

Summary: NFATs and FOXP3 are associated with impaired regulatory T-cells (Tregs) in generalized vitiligo (GV). This study investigated the calcium mediated NFATc1 signaling pathway and its effect on Treg suppressive capacity in GV. The results showed altered calcium homeostasis in GV Tregs, leading to decreased calcineurin and NFATc1 activity. Elevated GSK-3 beta activity and DYRK1A transcripts were also involved in reduced NFATc1 activity in GV Tregs. Calcium treatment enhanced Treg-mediated suppression and increased Tregs associated cytokines, suggesting the potential of calcium-NFATc1 signaling pathway as a therapeutic target for improving Treg function in GV.

IMMUNOLOGY (2022)

Review Immunology

Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo

Prashant S. Giri et al.

Summary: Vitiligo is a noncontagious autoimmune skin depigmenting disease. This meta-analysis study explores the role of regulatory T cells (Tregs) in vitiligo pathogenesis and finds that vitiligo patients have reduced Tregs' frequency, suppressive capacity, and key suppressive molecules such as FOXP3, IL-10, and TGF-beta. The study also suggests that Treg-based therapeutic interventions could be effective in vitiligo patients, supported by the increased Tregs' frequency and suppressive molecule expression after certain treatments.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Article Immunology

Decreased GZMB, NRP1, ITPR1, and SERPINB9 Transcripts Lead to Reduced Regulatory T Cells Suppressive Capacity in Generalized Vitiligo Patients

Prashant S. Giri et al.

Summary: This study reveals for the first time the critical role of GZMB, NRP1, SERPINB9, and ITPR1 transcripts in decreased Treg suppressive capacity in GV pathogenesis, progression, and severity. Furthermore, it suggests a correlation between ITPR1 and decreased expression of GZMB and NRP1 in GV Tregs. Additionally, the study suggests that increased SERPINB9 transcripts may lead to endogenous granzyme B-mediated Tregs apoptosis and that calcium treatment of Tregs may improve their suppressive capacity.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Article Cell Biology

lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response

Leah M. Plasek et al.

Summary: Genome-wide analyses have revealed the presence of numerous long noncoding RNAs (lncRNAs) with tissue- and state-specific expression patterns in immune cells. Functional studies on a small subset of these lncRNAs suggest they play a regulatory role in immune cell function. Despite their involvement in physiological processes, dysregulated lncRNA expression can contribute to pathological conditions in adaptive immunity.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Article Dermatology

The long noncoding RNA MALAT1 suppresses miR-211 to confer protection from ultraviolet-mediated DNA damage in vitiligo epidermis by upregulating sirtuin 1

H. D. Brahmbhatt et al.

Summary: This study identified a novel MALAT1-miR-211-SIRT1 signaling axis that potentially protects amelanotic keratinocytes in vitiligo. SIRT1 promotes keratinocyte differentiation, miR-211 overexpression leads to DNA damage, and MALAT1 acts as a negative upstream regulator of miR-211.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Biochemistry & Molecular Biology

Identification the Competing Endogenous RNA Networks in Oxidative Stress Injury of Melanocytes

Si Li et al.

Summary: Competing endogenous RNAs (ceRNAs) play a role in melanocyte injury under oxidative stress, potentially contributing to the pathogenesis of vitiligo. The complex changes in the ceRNA regulatory network are evident in the oxidative stress response of melanocytes.

DNA AND CELL BIOLOGY (2021)

Article Oncology

MicroRNA-21-5p protects melanocytes via targeting STAT3 and modulating Treg/Teff balance to alleviate vitiligo

Jing Huo et al.

Summary: This study found that in patients with vitiligo, the proportions of CD4(+) T cells, Treg cells, and T helper 1 (Th1) cells were decreased, while Teff cells (Th17 and Th22 cells) were increased. Additionally, miR-21-5p may protect melanocytes by targeting STAT3 and regulating Treg/Teff balance.

MOLECULAR MEDICINE REPORTS (2021)

Article Medicine, General & Internal

Expression patterns of long non-coding RNAs in peripheral blood mononuclear cells of non-segmental vitiligo

Shulan Zhang et al.

Summary: The study investigated the patterns of differentially expressed lncRNAs in the PBMCs of patients with non-segmental vitiligo, identifying ENST00000460164.1 and NR(-)046211.1 as potential biomarkers and drug targets for treatment. A network involving lncRNAs, miRNAs, and mRNAs was constructed to further explore the molecular mechanisms underlying non-segmental vitiligo.

MEDICINE (2021)

Review Biochemistry & Molecular Biology

LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides

Marco Bocchetti et al.

Summary: lncRNAs play a crucial role in regulating gene transcription during inflammatory responses, and recent studies have shown their dysregulation in human diseases is linked to immune mechanisms, offering insights into resolving complex disease relationships.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Down-Regulation of LOC645166 in T Cells of Ankylosing Spondylitis Patients Promotes the NF-κB Signaling via Decreasingly Blocking Recruitment of the IKK Complex to K63-Linked Polyubiquitin Chains

Hui-Chun Yu et al.

Summary: Ankylosing spondylitis (AS) is a chronic inflammatory disease associated with HLA-B27 expression, but other factors also play a role in its development. In AS patients, the levels of long non-coding RNA LOC645166 are reduced in T cells, impacting immune response regulation.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Translational Research in Vitiligo

Erica L. Katz et al.

Summary: Vitiligo is a skin disease characterized by white spots, and significant progress has been made in understanding its pathogenesis over the past 30 years through perseverance, collaboration, and open-minded discussion. Researchers have explored various possible mechanisms through innervation, microvascular anomalies, oxidative stress, defects in melanocyte adhesion, autoimmunity, somatic mosaicism, and genetics, with animal models and improved patient sample collection methods playing important roles in translational studies.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review

Fei Qi et al.

Summary: Vitiligo is a reversible skin disorder characterized by white patches resulting from destruction of melanocytes. JAK inhibitors have shown effectiveness in treating vitiligo by targeting the JAK/STAT pathway, but further studies are needed to determine optimal dosage and identify other inflammatory pathways involved in the pathogenesis of the condition.

FRONTIERS IN IMMUNOLOGY (2021)

Article Rheumatology

The safety of JAK-1 inhibitors

Benjamin Clarke et al.

Summary: As efficacy and safety data emerge, differences between JAK inhibitor subclasses are becoming evident. It is too early to conclude on distinct safety profiles between JAK1 selective agents and other JAK inhibitors, with further research needed for support. Monitoring infection risk, laboratory abnormalities, and herpes zoster reactivation are important considerations when using JAK inhibitors.

RHEUMATOLOGY (2021)

Article Dermatology

Tanshinone IIA alleviates vitiligo by suppressing AKT mediated CD8+ T cells activation in a mouse model

Diancai Zhang et al.

Summary: Tanshinone IIA alleviates vitiligo development by impairing CD8(+) T cell accumulation and activating the Pdk1-Akt pathway.

DERMATOLOGIC THERAPY (2021)

Review Pharmacology & Pharmacy

Emerging drugs for the treatment of vitiligo

Priyanka Karagaiah et al.

EXPERT OPINION ON EMERGING DRUGS (2020)

Article Medicine, General & Internal

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

David Rosmarin et al.

LANCET (2020)

Article Endocrinology & Metabolism

Levels of TNF-α, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo

Ebru Karagun et al.

AGING MALE (2020)

Review Cell Biology

Evolving complexity of MIF signaling

Stanislovas S. Jankauskas et al.

CELLULAR SIGNALLING (2019)

Review Immunology

T cell pathology in skin inflammation

Robert Sabat et al.

SEMINARS IN IMMUNOPATHOLOGY (2019)

Article Dermatology

Role of Janus kinase I and signal transducer and activator of transcription 3 in vitiligo

Rehab M. Samaka et al.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2019)

Letter Dermatology

Genome-Wide Association of PVT1 with Vitiligo

Songtao Ben et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Review Immunology

Signal Transducer and Activator of Transcription 3 Control of Human T and B Cell Responses

Elissa K. Deenick et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Biochemical Research Methods

Revealing protein-lncRNA interaction

Fabrizio Ferre et al.

BRIEFINGS IN BIOINFORMATICS (2016)

Article Dermatology

Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative

Nanja van Geel et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Article Medicine, General & Internal

Vitiligo

Khaled Ezzedine et al.

LANCET (2015)

Article Cardiac & Cardiovascular Systems

SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells

Kajari Dhar et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)

Article Biochemistry & Molecular Biology

The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier

Masaaki Murakami et al.

Biomedical Journal (2013)

Letter Dermatology

Positive link between STAT3 activation and Th17 Cell infiltration to the lesional skin in vitiligo vulgaris

Atsushi Tanemura et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2012)

Review Biochemistry & Molecular Biology

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

Sergei I. Grivennikov et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Review Immunology

Macrophage migration inhibitory factor: A regulator of innate immunity

T Calandra et al.

NATURE REVIEWS IMMUNOLOGY (2003)